Iron Deficiency Guidance Varies in Premenopausal Women
A Beyond the Guidelines discussion highlighted uncertainty around gastrointestinal evaluation and intravenous iron use in premenopausal women with iron deficiency.
By
Andrea Surnit
June 11, 2026
Clinical Scorecard: Iron Deficiency Guidance Varies in Premenopausal Women
At a Glance
Category Detail
Condition Iron Deficiency in Premenopausal Women Key Mechanisms Heavy menstrual bleeding, microcytosis, and low ferritin levels. Target Population Premenopausal women with iron deficiency. Care Setting Clinical practice, particularly in gynecology and gastroenterology.
Key Highlights
Iron deficiency may require treatment even without meeting anemia thresholds. Ferritin is a key noninvasive marker for iron deficiency. Bidirectional endoscopy is conditionally recommended for asymptomatic women with iron deficiency anemia. Intravenous iron may be preferred in cases of ongoing blood loss. Differing opinions exist on the necessity of gastrointestinal evaluation. Guideline-Based Recommendations
Diagnosis
Use ferritin as a primary marker for iron deficiency. Consider a Bayesian approach for diagnosis incorporating symptoms and lab results. Management
Oral iron is recommended first for most patients without urgent needs. Intravenous iron may be indicated for patients with heavy menstrual bleeding. Monitoring & Follow-up
Repeat laboratory testing after 4 to 6 weeks of iron therapy. Risks
Gastrointestinal evaluation may be overestimated in asymptomatic premenopausal women. Patient & Prescribing Data
Premenopausal women with iron deficiency and heavy menstrual bleeding.
Consider intravenous iron for rapid repletion in cases of ongoing blood loss.
Clinical Best Practices
Maintain a low threshold for gastrointestinal evaluation when iron deficiency causes are unclear. Differentiate between pseudoallergy and true hypersensitivity reactions to intravenous iron. Related Resources & Content
